Analysis of a maternal health medicines pipeline database 2000-2021: New candidates for the prevention and treatment of fetal growth restriction.

Shao LimAnnie R A McDougallMaya GoldsteinAndrew TuttleRoxanne HastieStephen TongAnne AmmerdorfferSara RushwanChristina RicciAhmet Metin GülmezogluJoshua P Vogel

Published in: BJOG : an international journal of obstetrics and gynaecology (2023)

l-Arginine, aspirin and vitamin D are promising, high-potential preventative agents for fetal growth restriction. Based on the medicines pipeline, new pharmacological agents for fetal growth restriction are unlikely to emerge in the near future.

Keyphrases

healthcare
public health
low dose
nitric oxide
mental health
cardiovascular events
type diabetes
emergency department
current status
coronary artery disease
pregnancy outcomes
acute coronary syndrome
adverse drug
preterm birth
health promotion
electronic health record